Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen

PA Regidor, A Mueller, M Mayr - Women's Health, 2023 - journals.sagepub.com
The spironolactone derivative drospirenone is combined with ethinylestradiol or estetrol in
combined oral contraceptives. Formulations with 17-β-estradiol are used to treat climacteric …

Sex differences in lipids: A life course approach

KB Holven, JR van Lennep - Atherosclerosis, 2023 - Elsevier
Differences between men and women in lipids and lipoproteins are observed in distribution
and trajectory from infancy to adulthood in the general population. However, these …

The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review

Ö Özcan, WPJ den Elzen, JJ Hillebrand… - Clinical Chemistry and …, 2024 - degruyter.com
Hormonal contraceptives (HC) are widely used among women in reproductive ages. In this
review, the effects of HCs on 91 routine chemistry tests, metabolic tests, and tests for liver …

The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users

MD Creinin, A Angulo, E Colli, DF Archer - Contraception, 2023 - Elsevier
Objectives This study aimed to compare contraceptive efficacy and safety of drospirenone 4
mg in a 24/4-day regimen in nonobese and obese users and describe pharmacokinetics …

[HTML][HTML] The benefits of estetrol addition to drospirenone for contraception

JM Foidart, K Gemzell-Danielsson, A Kubba… - AJOG global reports, 2023 - Elsevier
Ethinylestradiol and drospirenone combined oral contraceptive formulations have been
marketed for> 20 years. Drospirenone has antimineralocorticoid and anti-androgenic effects …

A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24+ 4 on coagulation markers and bleeding patterns

M Guida, L Quercitelli, P De Franciscis… - … European Journal of …, 2023 - Taylor & Francis
Abstract Purpose Progestin-only pills (POPs), compared to combined, are not associated
with an increased risk of venous thromboembolism, but are associated with a poor cycle …

[HTML][HTML] Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal

J Douxfils, L Morimont, MD Creinin… - … and Practice in …, 2023 - ncbi.nlm.nih.gov
We appreciate the response of LaVasseur et al.[1] to our Letter to the Editor on their article
on the risk of venous thromboembolism (VTE) with hormonal therapies, in which they remark …

The influence of combined oral contraceptive pills on carbohydrate metabolism in healthy women and in women with PCOS-a systemic review

K Wicha, R Wierciszewki, A Pokarowska… - Journal of Education …, 2022 - apcz.umk.pl
Abstract Introduction: Combined oral contraceptives (COCs) are a commonly used
contraceptive method. They are used as one of the method therapy in women with PCOS …

Oral Contraception: Beyond What Meets the Eye. Sorry, the Ovaries!

B Parapid, S Rakić - International Journal of Cardiovascular Sciences, 2022 - SciELO Brasil
Lamenting on the regrettable outcomes will surely not improve healthcare for women
worldwide who need it despite their respective countries' economies and social …

[HTML][HTML] Подростковая контрацепция, критерии выбора (мини-обзор)

МВ Денисенко, АД Алдохина - Акушерство и гинекология …, 2023 - cyberleninka.ru
Раннее начало половой жизни, а также недостаток сексуального образования ведут к
нежелательным последствиям, в частности подростковой беременности, риску …